Skip to main content English


5th - 8th May 2022

Programme for Download

Outline of Sessions

Session 1 - Tissue homeostasis

  • Thomas Weichhart (Vienna, Austria)
    Metabolic regulation of tissue homeostasis by macrophages
  • Stefan Uderhardt (Erlangen, Germany)
    A tissue-level perspective on inflammation

Session 2 - Genetics and antibodies

  • Matthew Brown (London, UK)
    Polygenic risk scores and rheumatology
  • Caroline Grönwall (Stockholm, Sweden)
    Autoreactivity to protein modifications in rheumatoid arthritis

Session 3 - Epigenetics

  • Esteban Ballestar (Barcelona, Spain)
    Epigenetics of inflammatory arthritis: Biological determinants and clinical applications
  • Sarah Rice (Newcastle upon Tyne, UK)
    Methylation matters: Unravelling the OA epigenome

Session 4 - Innate immunity

  • Chiara Romagnani (Berlin, Germany)
    Signatures of innate lymphoid cell activation and differentiation
  • Leonhard Heinz (Vienna, Austria)
    The SLC15A4/TASL complex – A new element in the pathogenesis of SLE?

Session 5 - Regenerative medicine and senescence

  • Johannes Grillari (Vienna, Austria)
    Tissue regeneration and aging: the senescence connection
  • Danièle Noel (Montpellier, France)
    Targeting senescent cells in osteoarthritis: an innovative therapeutic approach

Session 6 - B cells and T cells

  • Camilla Svensson (Stockholm, Sweden)
    Autoimmunity and neuroinflammation in fibromyalgia
  • Achilleas Floudas (Dublin, Ireland)
    Synovial T cell polyfunctionality in inflammatory arthritis

Session 7 - Organ and tissue inflammation

  • Ingrid Lundberg (Stockholm, Sweden)
    Myositis from bedside to bench, and back again
  • Oliver Distler (Zürich, Switzerland)
    Recent advances in understanding pathogenesis and therapy of scleroderma

Session 8 - Joint degeneration and repair

  • Liesbet Geris (Leuven, Belgium)
    An in silico perspective on osteoarthritis
  • Aline Bozec (Erlangen, Germany)
    Amelioration of bone loss by resolution of inflammatory pathways in arthritis

Session 9 - Precision medicine and novel targets

  • Christopher Buckley (Oxford, UK)
    The implications of the human cell atlas for targeting fibroblasts in immune mediated inflammatory diseases
  • Diane van der Woude (Leiden, The Netherlands)
    The long and winding road from health to disease in rheumatoid arthritis

Keynote lectures

  • Meinrad Busslinger (Vienna, Austria)
    Role of Pax5 in B cell development, immunity and disease
  • Sasha Mendjan (Vienna, Austria)
    Cardioids reveal self-organizing principles of human cardiogenesis
  • Costantino Pitzalis (London, UK)
    Molecular portraits of rheumatoid arthritis:
    Defining clinical and treatment response endotypes towards precision medicine

Meet our confirmed speakers for the EWRR 2022

  • Esteban Ballestar
    Epigenetics and Immune Disease Group, Josep Carreras Research Institute, Barcelona, Spain
  • Aline Bozec
    Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University, Erlangen-Nürnberg, Germany
  • Matthew Brown
    Genomics England, London; King’s College London, London, UK
  • Chris Buckley
    Kennedy Institute of Rheumatology, Oxford, UK
  • Meinrad Busslinger
    Research Institute of Molecular Pathology (IMP), Vienna, Austria
  • Oliver Distler
    Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, University of Zurich, Switzerland
  • Achilleas Floudas
    Department of Molecular Rheumatology,Trinity College Biomedical Sciences Institute,Trinity College Dublin, Dublin, Ireland
  • Liesbet Geris
    GIGA in silico medicine, University of Liège; Skeletal Biology & Engineering Research Center, KU Leuven, Belgium.
  • Johannes Grillari
    Ludwig Boltzmann Institute for Traumatology, Vienna, Austria
  • Caroline Grönwall
    Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
  • Leonhard Heinz
    Division of Rheumatology - Department of Medicine 3 - Medical University of Vienna, Austria
  • Ingrid Lundberg
    Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Sasha Mendjan
    IMBA - Institute of Molecular Biotechnology, Vienna, Austria
  • Daniele Noel
    Inserm U1183, Clinical Immunology and Osteoarticular Disease Therapeutic Unit, Department of Rheumatology, CHU Montpellier, France
  • Costantino Pitzalis
    Centre for Experimental Medicine & Rheumatology, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, UK
  • Sarah Rice
    Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK
  • Chiara Romagnani
    German Rheumatism Research Centre-a Leibniz Institute, Berlin, Germany
  • Camilla Svensson
    Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
  • Stefan Uderhardt
    Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander University Erlangen-Nürnberg, Germany
  • Thomas Weichhart
    Center for Pathobiochemistry and Genetics, Medical University of Vienna, Austria
  • Diane van der Woude
    Department of Reumatology - Leiden University Medical Centre, Leiden, The Netherlands